FCCC LOGO Faculty Publications
Marshall J , Hwang J , Eskens Falm , Burger H , Malik S , Uttenreuther-Fischer M , Stopfer P , Ould-Kaci M , Cohen RB , Lewis NL
A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors
Investigational New Drugs. 2013 Apr;31(2) :399-408
PMID: WOS:000316081900016    PMCID: PMC3589659   
Back to previous list
Abstract
Notes
Marshall, John Hwang, Jimmy Eskens, Ferry A. L. M. Burger, Herman Malik, Shakun Uttenreuther-Fischer, Martina Stopfer, Peter Ould-Kaci, Mahmoud Cohen, Roger B. Lewis, Nancy L.